fda tirzepatide Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes FDA approval for Zepbound (tirzepatide)

Personalized Compounding Solutions For Wisconsin medspas, clinics and physicians Sexual Health We provide personalized compounds to support sexual health, from enhancing libido and performance to easing erectile dysfunction or vaginal drynesshelping patients across Wisconsin regain confidence, intimacy, and well-being

Affordable: Generally less expensive than injectable formulations

15 Phase II trials targeting MASH have shown that treatment with SEMA 0.4 mg daily for 72 weeks resulted in more patients with liver fibrosis stage F2/F3 achieving improvement in MASH without progression of liver fibrosis (odds ratio = 6.87, 95% CI = 2.6017.63) compared to placebo

You feel full for a longer period of time and you eat less, without having to tempt temptations